N-叔丁基-2-氯吡啶-4-甲酰胺 | 588694-28-4

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: N-叔丁基-2-氯吡啶-4-甲酰胺
• 中文别名: N-叔丁基-2-氯异烟酰胺
• 英文名称: N-(tert-butyl)-2-chloropyridine-4-carboxamide
• 英文别名: N-(tert-butyl)-2-chloroisonicotinamide；N-Tert-butyl-2-chloroisonicotinamide；N-tert-butyl-2-chloropyridine-4-carboxamide
• CAS: 588694-28-4
• 化学式: C₁₀H₁₃ClN₂O
• 分子量: 212.679
• InChiKey: AJRNKJBMKLQFIM-UHFFFAOYSA-N

物化性质

• 熔点：
  97-98 °C
• 沸点：
  346.8±27.0 °C(Predicted)
• 密度：
  1.152±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
N-tert-Butyl-2-chloroisonicotinamide
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P302+P352: IF ON SKIN: Wash with soap and water
P321: Specific treatment (see on this label)
P405: Store locked up

---

Section 3. Composition/information on ingredients.
N-tert-Butyl-2-chloroisonicotinamide
Ingredient name:
CAS number: 588694-28-4

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H13ClN2O
Molecular weight: 212.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-叔丁基-2-氯吡啶-4-甲酰胺 在 重水 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以80%的产率得到
  参考文献：
  名称：

  Deprotonation of pyridine carboxamides using lithium magnesiates bases

  摘要：

  Regioselective deprotonation of N-methyl- and tert-butylpyridine carboxamides using lithium magnesiates bases was achieved at room temperature avoiding nucleophilic addition on the pyridine molecule and auto-condensation of the arylmetal intermediates on the amide group was described. The hydrogen-magnesium exchange was evidenced using H-1 NMR spectroscopy at room temperature and the reactivity of the lithium 2- 3- and 4-carboxamidopyridinylmagnesiates complexes towards electrophiles and in cross-coupling reactions was studied. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2008.01.064
• 作为产物：
  描述：

  2-氯异烟酸 在 氯化亚砜 、 三乙胺 作用下， 以 苯 为溶剂， 反应 2.0h， 生成 N-叔丁基-2-氯吡啶-4-甲酰胺
  参考文献：
  名称：

  摘要：

  DOI：

  10.1023/a:1021258510259

文献信息

• Palladium-catalysed aminocarbonylation of diiodopyridines
  作者：Attila Takács、Georgina Márta Varga、Johanna Kardos、László Kollár

  DOI：10.1016/j.tet.2017.02.062

  日期：2017.4

  The aminocarbonylation of 2,5- and 2,3-diiodopyridine, as well as 2-chloro-3,4-diiodopyridine with carbon monoxide and various primary and secondary amines was carried out using palladium-catalysed aminocarbonylation. The formation of the products containing carboxamide and ketocarboxamide functionalities was accompanied by the formation of imides when ortho-diiodo compounds were used as substrates

  2，5-和2，3-二碘吡啶以及2-氯-3，4-二碘吡啶与一氧化碳以及各种伯胺和仲胺的氨基羰基化反应是通过钯催化的氨基羰基化反应进行的。当使用邻二碘代化合物作为底物时，形成含有羧酰胺和酮羧酰胺官能团的产物伴随着酰亚胺的形成。尽管有几种可能的反应途径，但通过适当地改变反应条件，大多数产物被合成为主要产物，具有合成目的的产率。
• Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors
  申请人：Fleck Roman Wolfgang

  公开号：US20090227588A1

  公开（公告）日：2009-09-10

  Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same.

  本发明涉及对可溶性环氧水解酶（sEH）活性的化合物，其组成物和使用和制备它们的方法。
• Discovery of CH7057288 as an Orally Bioavailable, Selective, and Potent pan-TRK Inhibitor
  作者：Toshiya Ito、Kazutomo Kinoshita、Masaki Tomizawa、Shojiro Shinohara、Hiroki Nishii、Masayuki Matsushita、Kazuo Hattori、Yasunori Kohchi、Masami Kohchi、Tadakatsu Hayase、Fumio Watanabe、Kiyoshi Hasegawa、Hiroshi Tanaka、Shino Kuramoto、Kenji Takanashi、Nobuhiro Oikawa

  DOI：10.1021/acs.jmedchem.2c01099

  日期：2022.9.22

  unique tetracyclic scaffold. Compound 1 showed high TRK selectivity but moderate cell growth inhibitory activity as well as a potential risk of inducing CYP3A4. In this report, chemical modification intended to improve TRK inhibition and avoid CYP3A4 induction enabled us to identify an orally bioavailable, selective, and potent TRK inhibitor 7.

  涉及原肌球蛋白受体激酶 (TRK) 的激酶融合已被证明可作为强大的致癌驱动因子，因此被认为是有吸引力的治疗靶点。我们筛选了一个以激酶为中心的内部库，并确定了一种具有独特四环支架的有希望的命中化合物。化合物1显示出高 TRK 选择性，但具有中等的细胞生长抑制活性以及诱导 CYP3A4 的潜在风险。在本报告中，旨在改善 TRK 抑制和避免 CYP3A4 诱导的化学修饰使我们能够确定一种口服生物可利用的、选择性的和有效的 TRK 抑制剂7。